Poultry Vaccines Market is expected to Reach the Valuation of USD 3.60 Billion by 2030, Size, Share, Growth, Trends, Demand and Opportunity Analysis

Data Bridge Market Research analyses that the poultry vaccines market, which was USD 2.0 billion in 2022, would rise to USD 3.60 billion by 2030 and is expected to undergo a CAGR of 7.6% during the forecast period 2023 to 2030

| Quelle: Data Bridge Market Research Data Bridge Market Research

OTTAWA, March 30, 2023 (GLOBE NEWSWIRE) -- Data Bridge Market research has published a report on the "Poultry Vaccines Market," which covers several regions including the USA, Europe, China, Japan, India, South East Asia, and more. The report provides a comprehensive analysis of the market's opportunities and risks and helps decision-makers make strategic and tactical decisions with confidence. An influential Poultry Vaccines market research report can save significant cost and time and can help prevent making costly mistakes. The report is focused on directly answering the project objectives and thus helping clients make better business decisions. The objective is the starting point of this report as it justifies the expense of conducting the research. A creative market analyst team uses the format that best communicates the information. This market report is kept short and many white spaces and bullet points have been used as too much text on a page can be intimidating and discourage readership.

The solid foundation required to fulfill the variety of business challenges that come along can be provided by the leading Poultry Vaccines business report. To generate this report, goals are set and primary and secondary segments are decided to get the grips with the kind of information required to achieve effective results. The report is very concise and accurate is straight to the point and also don’t omit any essential information. All the collected market data is cleaned and organized before formulating an excellent market report. The complete Poultry Vaccines market research report has an executive summary that explains the general idea of the report.

Data Bridge Market Research analyses that the poultry vaccines market, which was USD 2.0 billion in 2022, would rise to USD 3.60 billion by 2030 and is expected to undergo a CAGR of 7.6% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Download Sample PDF of the Poultry Vaccines Market @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-poultry-vaccines-market

Poultry vaccine helps prevent a specific disease by considerably accelerating their immune system to develop antibodies to battle against the invading organisms. Poultry vaccines play a major role in poultry disease control and prevention. The majority of poultry-killed vaccines are developed to fight against viral diseases. These vaccines are administered in different forms, such as nasal, oral, ocular, vivo, subcutaneous, and intramuscular. 

The increasing poultry population and the growing prevalence of avian diseases are anticipated to enhance the demand for poultry vaccines. There is a surge in demand for poultry vaccines because of the number of zoonotic cases. For instance, as per an article published by the world health organization, a U.S.-based government agency, there is a 64% rise in the number of zoonotic cases in Africa in 2022. Numerous companies operating in the poultry vaccine market are primarily focused on launching new technological solutions to boost their position.

The Global Market Is Analyzed in Depth in the Latest Study. Taking into account the current level of competition and its projected evolution over the next few years.

Rapidly increasing demands, a rise in industrialization, consumer awareness, growing sectors, and technical improvements are fueling the expansion of the global Poultry Vaccines market. Sales and revenue in this sector have increased at an exponential rate. The market's size and growth are both expected to increase thanks to the factors driving the market's expansion over the projected period.

Leading businesses in the worldwide Poultry Vaccines market are investing heavily in R&D in order to build a larger client base and expand their share of the market by reintroducing improved products to consumers. All of the companies' strategy, as well as their financial health, revenue, gross margin, and growth rate, are detailed in the study.

Recent Development

  • In 2020, Boehringer Ingelheim launched the VAXXITEK HVT+IBD+ND vaccine to protect poultry against Marek's Disease, Newcastle Disease, and Infectious Bursal Disease (classic and variant types). Boehringer Ingelheim will produce VAXXITEK HVT+IBD+ND from its site which develops more than 60 billion doses of poultry vaccine a year for use in the U.S. and over 60 other countries.

Some of the major players operating in the poultry vaccines market are:

  • Boehringer Ingelheim International GmbH. (Germany)
  • Zoetis (U.S.)
  • Dechra Pharmaceuticals PLC (U.K.)
  • Hester Biosciences Limited. (India)
  • Merck & Co., Inc. (U.S)
  • Novartis AG (Switzerland)
  • Elanco (U.S.)
  • Phibro Animal Health Corporation (U.S.)

Download the Complete Research Study Here in PDF Format @ https://www.databridgemarketresearch.com/checkout/buy/enterprise/global-poultry-vaccines-market

Key Points of The Report:

Market Overview: The report begins with this section where a product overview and key content on the product and application segments of the global Poultry Vaccines market are provided.

Market Forecast: Here the report provides a full forecast for the global Poultry Vaccines market by product, application, and region. It also provides global sales and revenue forecasts for all years in the forecast period.

Competition by Company: Here we analyze the competition of the global Poultry Vaccines market, by company price, revenue, sales and market share, market share, competitive landscape, and latest trends, mergers, expansions, acquisitions, and market share of top companies.

Research Results and Conclusion: One of the last sections of the report where analyst findings and findings are provided.

Opportunities:

  • Increasing Prevalence of Avian Influenza

As per the data of the World Health Organization, two new outbreaks of highly pathogenic avian influenza (HPAI) A(H5N2) among birds were witnessed. Among 9,578 susceptible birds identified were around 1,819 deaths, and the remaining 7,759 highly infected poultry. Additionally, the CDC has stated that the mortality for this disease is about 90%-100%. This increasing outbreak led to a huge improvement in market growth. Thus, this factor boosts market growth.  

  • Increasing Usage of Inactivated Vaccines

Inactivated vaccines have been widely utilized recently, leading to increased market growth. This is because of its easy availability, low cost, and stability advantages over live-attenuated vaccines. They decrease the chances of virus recurrence after vaccination, as it helps to prevent the replication process of pathogens. Furthermore, it provides swine with better immunization with a rapid cell-mediated immune response. Thus, this factor serves as a major factor that increases market growth.

Key Drivers:

  • Increasing Research Activities Associated with Poultry vaccines

The growing R&D activities by the major market players for launching poultry vaccines to treat diseases and growing product approvals are expected to increase the market's growth during the forecast period. For instance, Venkys India provides a huge range of poultry vaccines, including the Salmonella polyvalent inactivated vaccine used to prevent and control salmonellosis in breeders, layers, and broilers. OILVAX EDS-76 is also a part of the portfolio of KM Biologics and is very effective against egg drop syndrome. This factor leads to the growth of the market.

  • Huge Technological Advancements by Market Players

Several companies operating in the poultry vaccine market are focused on launching new technological solutions to boost their position. For instance, Boehringer Ingelheim, a Germany-based pharmaceutical company, launched the VAXXITEK HVT+IBD+ND vaccine to protect poultry from three types of diseases in 2020. VAXXITEK HVT+IBD+ND boosts a solid immune foundation and offers improved protection against infectious bursal disease (classic and variant kinds), Marek's disease, and Newcastle disease. Thus, this factor help in the market growth.

Access the Detailed PDF Research Report @ https://www.databridgemarketresearch.com/reports/global-poultry-vaccines-market

Key Market Segments Covered in Poultry Vaccines Industry Research

Product Type

  • Modified or Attenuated (Live)
  • Recombinants

Dosage Form

  • Liquid Vaccine
  • Freeze Dried Vaccine
  • Duct

Disease Type

  • Marek's Disease
  • Infectious Bronchitis
  • Infectious Bursal Disease
  • Others

Application

  • Breeder
  • Broiler
  • Layer

End User

  • Hospitals
  • Poultry Vaccination Centres
  •  Poultry Firms

Poultry Vaccines Market Regional Analysis/Insights:

The countries covered in the poultry vaccines market report are the U.S., Canada, and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of the Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Asia-Pacific is expected to grow during the forecast period of the poultry vaccines market due to increasing investment in animal health and a persistent rise in demand for poultry-derived products. Also, the huge presence of top poultry production countries, such as China, and a large meat-consuming population, are boosting the market growth.

North America dominates the market in the forecast period due to the increasing technological advancement and the presence of major market players of the market. Other factors which surge the demand for poultry vaccines in this region are the rising government initiatives and huge improvements in animal husbandry practices.

Table of Contents:

  1. Introduction
  2. Market Segmentation
  3. Executive Summary
  4. Premium Insights
  5. Global Poultry Vaccines Market: Regulations
  6. Market Overview
  7. Global Poultry Vaccines Market, By Product Type
  8. Global Poultry Vaccines Market, By Dosage Form
  9. Global Poultry Vaccines Market, By Disease Type
  10. Global Poultry Vaccines Market, By End User
  11. Global Poultry Vaccines Market, By Application
  12. Global Poultry Vaccines Market, By Region
  13. Global Poultry Vaccines Market: Company Landscape
  14. SWOT Analyses
  15. Company Profile
  16. Questionnaires
  17. Related Reports

To Examine The Complete Table Of Contents, Click Here @ https://www.databridgemarketresearch.com/toc/?dbmr=global-poultry-vaccines-market

Explore More Reports:

  • Poultry Diagnostics Market, By Test Type (Enzyme Linked Sorbent Assay (ELISA), Polymerase Chain Reaction Tests (PCR), Others), Disease Type (Avian Salmonellosis, Avian Influenza, Newcastle Disease, Avian Mycoplasmosis, Infectious Bronchitis, Infectious Bursal Disease, Avian Pasteurellosis, Avian Encephalomyelitis, Avian Reovirus, Chicken Anemia), Service Type (Bacteriology, Parasitology and Virology), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa) https://www.databridgemarketresearch.com/reports/global-poultry-diagnostics-market
  • Human rotavirus vaccine market, By type (Rotarix, RotaTeq, Rotavac, Rotavin-M1, Lanzhou lamb, others), End Users (Hospitals and Clinics, Academic and Research, Others), Application (Hospitals and Clinics, Academic and Research), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) https://www.databridgemarketresearch.com/reports/global-human-rotavirus-vaccine-market
  • Vaccine Adjuvants Market By Product Type (Particulate Adjuvants, Adjuvant Emulsions, Pathogen Components, Combination Adjuvants, Liposome Adjuvants, Carbohydrate Adjuvants, Alum and Others), Route of Administration (Intramuscular Route, Subcutaneous Route, Intranasal Route, Oral Route, Intradermal Route and Others), Disease Type (Infectious Diseases, Cancer and Others), Application (Research Application and Commercial Application), Application Category (Human Vaccine Adjuvants and Veterinary Vaccine Adjuvants), End User (Paediatric, Adults and Others), Country (U.S., Canada, Mexico, Peru, Brazil, Argentina, Rest of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia Pacific, South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa) https://www.databridgemarketresearch.com/reports/global-vaccine-adjuvants-market
  • Veterinary Clostridium Vaccine Market, By Disease (Swine Pneumonia, Avian Influenza, Rabies, Coccidiosis, Brucellosis, Canine Distemper), Type (Poultry, Livestock, Aquaculture, Porcine, Canine), Technology (Inactivated, Toxoid, Recombinant), Distribution Channel (Veterinary Hospital, Veterinary Clinic, Veterinary Research Institute, Retail Pharmacy), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) https://www.databridgemarketresearch.com/reports/global-veterinary-clostridium-vaccine-market
  • Deoxyribonucleic Acid (DNA) Vaccines Market , By Type (Human DNA Vaccines, Animal DNA Vaccines), Technology (pDNA Vaccines Technology, pDNA Delivery Technology), Application (Human Diseases, Veterinary Diseases Allergies, Others), End-User (Human Health, Animal Health, Research Application), Therapeutic Indications (Vector Borne Disease, Cancer), Type of Vaccines (Genetic Vaccines, Recombinant Protein Vaccines), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa)               https://www.databridgemarketresearch.com/reports/global-dna-vaccines-market
  • Personalized Cancer Vaccines Market, By Cancer Type (Lung Cancer, Breast Cancer, Colorectal Cancer, Leukaemia, Prostate Cancer, Cervical Cancer and Glioblastoma), Mechanism of Action Type (Tumour-associated Antigens (TAAs), Tumour-specific Antigens (TSAs), Somatic Mutations in Cancer Pharmacogenomics, Pharmacogenomics towards Genomic Polymorphism), Technology (Dendritic Cells (DC) Cancer Vaccines, Recombinant Cancer Vaccines, Antigen/Adjuvant Cancer Vaccines and Viral Vector and DNA Cancer Vaccines), Bio-maker Type (Pharmacogenomics, Prognostic and Predictive Biomarkers, Immune Checkpoint Biomarkers and Others), Treatment Type (Preventive Cancer Vaccines and Therapeutic Cancer Vaccines), Route of Administration (Injectable and Others), End Users (Hospitals, Homecare, Specialty Clinics, Others), Country https://www.databridgemarketresearch.com/reports/global-personalized-cancer-vaccines-market
  • Conjugate Vaccines Market, By Type (Monovalent Conjugate Vaccines, Multivalent Conjugate Vaccines), Indication (Pneumococcal Disease, Influenza, Meningococcal Disease, Others), End Users (Hospitals, homecare, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy), and Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) https://www.databridgemarketresearch.com/reports/global-conjugate-vaccines-market
  • Toxoid vaccines market, By Type (Tetanus Vaccines, Diphtheria Vaccines, Pertussis Vaccines, Others), Indication (Tetanus, Diphtheria, Pertussis, Others), End-Users (Hospitals, Specialty Centres, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy), Country (U.S., Canada, Mexico, Peru, Brazil, Argentina, Rest of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia Pacific, South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa) https://www.databridgemarketresearch.com/reports/global-toxoid-vaccines-market
  • Live Attenuated Vaccines Market, By Product Type (Bacterial, Viral), Development (Tissue Culture, Embryonated Eggs, Live Animals), Indication (Tuberculosis, Measles, Rotavirus, Yellow Fever, Oral Polio, Others), Mode of Administration (Injectable, Oral, Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), End User (Hospitals, Homecare, Specialty Clinics, Others), Country (U.S., Canada, Mexico, Peru, Brazil, Argentina, Rest of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia Pacific, South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa) https://www.databridgemarketresearch.com/reports/global-live-attenuated-vaccines-market
  • Pneumococcal Vaccine Market, By Vaccine Type (Pneumococcal Conjugate Vaccine, Pneumococcal Polysaccharide Vaccine), Product Type (Prevnar 13, Synflorix, Pneumovax 23, Others), Route of Administration (Intravenous, Intramuscular, Subcutaneous), End Users (Hospitals, Specialty Clinics, Others), Distribution Channel (Distribution Partner Companies, Non-governmental Organizations (NGO), Others), Country (U.S., Canada, Mexico, Peru, Brazil, Argentina, Rest of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia Pacific, South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa) https://www.databridgemarketresearch.com/reports/global-pneumococcal-vaccine-market
  • Porcine Vaccines Market, By Indication (Swine Fever, Porcine Parvovirus, Aujeszky's Disease, Swine Colibacillosis, Porcine Pneumonia, Porcine Pleropneumoniae, Others), Technology (Inactivated Vaccines, Live Attenuated Vaccines, Toxoid Vaccines, Recombinant Vaccines, Conjugate Vaccines, DNA Vaccines), Product Type (Improvac, Suvaxyn, Circumvent, Circovac, Others), Route of Administration (Intravenous, Intramuscular, Others), End Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy, Others), Country (U.S., Canada, Mexico, Peru, Brazil, Argentina, Rest of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia Pacific, South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa) https://www.databridgemarketresearch.com/reports/global-porcine-vaccines-market
  • Vaccine Market, By Technology  (Conjugate Vaccines, Inactivated and Subunit Vaccines, Live Attenuated Vaccines, Others), Type (Monovalent Vaccines, Multivalent Vaccines), Indication (Pneumococcal Disease, Influenza,  Meningococcal Disease, Polio, Rotavirus, Hepatitis, Dengue, Herpes Zoster, Others), Route of Administration (Oral, Parenteral), End-Users (Clinic, Hospital, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) https://www.databridgemarketresearch.com/reports/global-vaccine-market

About Data Bridge Market Research:

An absolute way to forecast what the future holds is to comprehend the trend today!

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

Contact Us:

Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email:- corporatesales@databridgemarketresearch.com


Tags

Poultry Vaccines Market Poultry Vaccines Market Share Poultry Vaccines Market Size Poultry Vaccines Poultry Vaccines size

Weiterführende Links